Research Paper Volume 13, Issue 1 pp 769—781
The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma
Figure 1. Detection of has-miR-29c expression in HNSCC. (A) The overlap among three expression datasets described in Methods included the significant miRNAs has-miR-29c, has-miR-210, has-miR-18a. (B) The levels of miR-29c-5p in a clinical cohort were significantly lower in HNSCC tissues compared with normal tissues (P<0.05). (C) Survival curves suggest that decreased miR-29c-5p expression was significantly associated with unfavorable prognosis of patients with HNSCC. (D) Compared with the normal control, the levels of miR-29c-5p were significantly lower in FaDu and HSC-3 cells. *p < 0.05, **p < 0.01.